Alcohol Raises Cancer Risk in New Analysis

A new analysis published Monday in Nature Health says alcohol consumption is linked to higher risks for a wide range of cancers and liver diseases, while some cardiovascular and metabolic outcomes still show mixed or U-shaped patterns at lower intake levels.

The study reviewed 843 cohort and case-control studies published from 1961 through 2023 and reexamined the dose-response relationship between alcohol and 20 health outcomes using a conservative statistical framework known as Burden of Proof. The authors said the goal was to compare risks across diseases more consistently than many earlier meta-analyses, which often focused on one condition at a time and used different reference groups.

The findings add to a long-running public health debate in the United States over how alcohol should be labeled, taxed and discussed in medical settings, especially as federal officials and clinicians have increasingly questioned whether any level of drinking can be considered safe. The results are relevant for wine, beer and spirits alike, since the analysis looked at alcohol itself rather than beverage type.

According to the study, current alcohol consumption was associated with increased risk for cancers of the breast, colorectum, esophagus, larynx, lip and oral cavity, pharynx, liver, stomach, pancreas and prostate. It was also linked to pancreatitis, cirrhosis and other chronic liver diseases, lower respiratory infections, tuberculosis, atrial fibrillation and flutter.

The strongest association in the analysis was for other pharyngeal cancer. The researchers said alcohol consumption within the typical exposure range was associated with at least a 105% increase in risk for that cancer. They also found substantial increases in risk for cirrhosis and other chronic liver diseases, laryngeal cancer, pancreatitis, colorectal cancer and lip and oral cavity cancer.

For some conditions, including type 2 diabetes, Alzheimer’s disease and other dementias, ischemic heart disease and certain strokes, the data showed J-shaped or U-shaped curves. That means risk appeared lower at some low-to-moderate intake levels before rising again at higher levels. But the authors emphasized that these patterns varied by outcome and did not hold across all diseases.

The paper said high levels of alcohol consumption were associated with increased risk across every outcome studied. At lower levels, the picture was more complicated. For example, the analysis found that type 2 diabetes risk appeared lowest around 18 grams of alcohol per day before rising again. For ischemic heart disease, risk also appeared lower at moderate intake before increasing at higher levels.

The researchers said they used a conservative approach that adjusted for study design differences, publication bias where possible and remaining heterogeneity between studies. They noted that this method is intended to provide a cautious estimate of the evidence rather than an exact measure of harm or benefit.

Public health experts have long warned that alcohol contributes to cancer risk even at relatively low intake levels. In recent years, several countries have revised drinking guidelines or warning labels to reflect that evidence. In the United States, federal dietary guidance has continued to advise moderation while acknowledging uncertainty about whether any amount of alcohol is beneficial.

The new study is likely to intensify pressure on policymakers as they weigh whether warning labels should say more about cancer risk. It may also influence doctors who counsel patients about drinking habits during routine care, particularly for people with family histories of cancer or liver disease.

The authors said nearly half of adults worldwide regularly consume alcohol, making it important to understand its full health effects. They argued that inconsistent drinking guidelines leave many people unclear about what level of intake, if any, can be considered safe.

The analysis did not separate wine from beer or spirits in its main conclusions. Instead, it treated ethanol exposure as the key factor. That means the findings apply broadly to alcoholic drinks sold in bars, restaurants and retail stores across the United States.

For consumers who have been told that moderate drinking may protect the heart, the study offers a more cautious reading of the evidence. It suggests that any possible benefit at low intake is limited to certain outcomes and may be outweighed by increased risks for cancers and liver disease as consumption rises.